234 related articles for article (PubMed ID: 20692189)
1. Sunitinib may raise the risk of bisphosphonate-related osteonecrosis of the jaw: presentation of three cases.
Hoefert S; Eufinger H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):463-9. PubMed ID: 20692189
[TBL] [Abstract][Full Text] [Related]
2. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
Bozas G; Roy A; Ramasamy V; Maraveyas A
Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
[TBL] [Abstract][Full Text] [Related]
3. Osteonecrosis of the jaws in patients assuming bisphosphonates and sunitinib: two case reports.
Agrillo A; Nastro Siniscalchi E; Facchini A; Filiaci F; Ungari C
Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):952-7. PubMed ID: 22953645
[TBL] [Abstract][Full Text] [Related]
4. Osteonecrosis of the jaw related to sunitinib.
Koch FP; Walter C; Hansen T; Jäger E; Wagner W
Oral Maxillofac Surg; 2011 Mar; 15(1):63-6. PubMed ID: 20401503
[TBL] [Abstract][Full Text] [Related]
5. Nationwide survey for bisphosphonate-related osteonecrosis of the jaws in Japan.
Urade M; Tanaka N; Furusawa K; Shimada J; Shibata T; Kirita T; Yamamoto T; Ikebe T; Kitagawa Y; Fukuta J
J Oral Maxillofac Surg; 2011 Nov; 69(11):e364-71. PubMed ID: 21782307
[TBL] [Abstract][Full Text] [Related]
6. The role of surgical resection in the management of bisphosphonate-related osteonecrosis of the jaws.
Carlson ER; Basile JD
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):85-95. PubMed ID: 19371819
[TBL] [Abstract][Full Text] [Related]
7. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
Nicolatou-Galitis O; Migkou M; Psyrri A; Bamias A; Pectasides D; Economopoulos T; Raber-Durlacher JE; Dimitriadis G; Dimopoulos MA
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):234-8. PubMed ID: 22669112
[TBL] [Abstract][Full Text] [Related]
8. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
Brunello A; Saia G; Bedogni A; Scaglione D; Basso U
Bone; 2009 Jan; 44(1):173-5. PubMed ID: 18849018
[TBL] [Abstract][Full Text] [Related]
9. Sunitinib related osteonecrosis of jaw: a case report.
Fleissig Y; Regev E; Lehman H
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Mar; 113(3):e1-3. PubMed ID: 22676833
[TBL] [Abstract][Full Text] [Related]
10. Tooth extraction in patients receiving oral or intravenous bisphosphonate administration: A trigger for BRONJ development?
Otto S; Tröltzsch M; Jambrovic V; Panya S; Probst F; Ristow O; Ehrenfeld M; Pautke C
J Craniomaxillofac Surg; 2015 Jul; 43(6):847-54. PubMed ID: 25958767
[TBL] [Abstract][Full Text] [Related]
11. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator.
O'Ryan FS; Khoury S; Liao W; Han MM; Hui RL; Baer D; Martin D; Liberty D; Lo JC
J Oral Maxillofac Surg; 2009 Jul; 67(7):1363-72. PubMed ID: 19531404
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study evaluating frequency and risk factors of osteonecrosis of the jaw in 576 cancer patients receiving intravenous bisphosphonates.
Thumbigere-Math V; Tu L; Huckabay S; Dudek AZ; Lunos S; Basi DL; Hughes PJ; Leach JW; Swenson KK; Gopalakrishnan R
Am J Clin Oncol; 2012 Aug; 35(4):386-92. PubMed ID: 22561331
[TBL] [Abstract][Full Text] [Related]
13. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
Soós B; Vajta L; Szalma J
Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonate-related osteonecrosis of the jaw: clinical features, risk factors, management, and treatment outcomes of 26 patients.
Thumbigere-Math V; Sabino MC; Gopalakrishnan R; Huckabay S; Dudek AZ; Basu S; Hughes PJ; Michalowicz BS; Leach JW; Swenson KK; Swift JQ; Adkinson C; Basi DL
J Oral Maxillofac Surg; 2009 Sep; 67(9):1904-13. PubMed ID: 19686928
[TBL] [Abstract][Full Text] [Related]
15. Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.
Dodson TB
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):44-52. PubMed ID: 19371814
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
O'Ryan FS; Lo JC
J Oral Maxillofac Surg; 2012 Aug; 70(8):1844-53. PubMed ID: 22595135
[TBL] [Abstract][Full Text] [Related]
17. Oral bisphosphonates as a cause of bisphosphonate-related osteonecrosis of the jaws: clinical findings, assessment of risks, and preventive strategies.
Assael LA
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):35-43. PubMed ID: 19371813
[TBL] [Abstract][Full Text] [Related]
18. Serologic bone markers for predicting development of osteonecrosis of the jaw in patients receiving bisphosphonates.
Lazarovici TS; Mesilaty-Gross S; Vered I; Pariente C; Kanety H; Givol N; Yahalom R; Taicher S; Yarom N
J Oral Maxillofac Surg; 2010 Sep; 68(9):2241-7. PubMed ID: 20728033
[TBL] [Abstract][Full Text] [Related]
19. A study of 225 patients on bisphosphonates presenting to the bisphosphonate clinic at King's College Hospital.
Taylor T; Bryant C; Popat S
Br Dent J; 2013 Apr; 214(7):E18. PubMed ID: 23579162
[TBL] [Abstract][Full Text] [Related]
20. [Encounter of cancer cells with bone. Present status and problems in occurrence of bisphosphonate-related osteonecrosis of the jaws].
Urade M
Clin Calcium; 2011 Mar; 21(3):420-7. PubMed ID: 21358064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]